US 11230712
Compounds and methods for reducing SNCA expression
granted A61KA61K31/7115A61K31/712
Quick answer
US patent 11230712 (Compounds and methods for reducing SNCA expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/7115, A61K31/712, A61K31/7125, A61P